June 10, 2024 – Page 7 – Goldea Capital

DFDS DIVESTS OSLO CRUISE FERRY ROUTE TO ENHANCE TRANSPORT FOCUS

Written by Customer Service on June 10, 2024. Posted in Public Companies.

INVESTOR NEWS no. 42 – 10 June 2024 DFDS has today entered into an agreement to divest the Oslo-Frederikshavn-Copenhagen (OFC) cruise ferry route to Gotlandsbolaget. Completion of the agreement is expected in October 2024. The OFC route annually carries more than 700,000 passengers between Norway and Denmark. The route deploys two cruise ferries and has just over 800 sea- and land-based employees. Revenue in 2023 was DKK 0.9bn equal to 3% of the DFDS Group’s total revenue. “It is with a heavy heart that we have found a new home for the Oslo route as it has been a part of DFDS since our foundation in 1866 and in addition a cherished public institution in Denmark and Norway. DFDS is however today a transport and logistics company bridging Europe and the route deserves a new owner that can continue to invest in and develop the...

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Written by Customer Service on June 10, 2024. Posted in Mergers And Acquisitions.

On June 10, 2024, Delfi Meedia AS, 100% subsidiary of AS Ekspress Grupp, entered into the contract for the acquisition of business operations of OÜ Eesti Koolitus- ja Konverentsikeskus (EKKK). The transaction is scheduled to be completed on July 1, 2024. The acquisition aims to facilitate Delfi Meedia’s expansion into Estonia’s training and conference business market. Ekspress Grupp identifies significant growth potential and opportunities for synergy with the Group’s existing operations. Eesti Koolitus- ja Konverentsikeskus OÜ, established in 2010, stands as the leading organizer of training sessions, seminars and conferences in Estonia. Annually the company organises over 700 unique training programs and seminars both domestically and internationally, alongside a dozen high-profile vision and professional conferences. Many of...

Shell plc First Quarter 2024 Euro and GBP Equivalent Dividend Payments

Written by Customer Service on June 10, 2024. Posted in Dividend Reports And Estimates.

SHELL PLC FIRST QUARTER 2024 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS June 10, 2024 The Board of Shell plc today announced the pounds sterling and euro equivalent dividend payments in respect of the first quarter 2024 interim dividend, which was announced on May 2, 2024 at US$0.344 per ordinary share. Shareholders have been able to elect to receive their dividends in US dollars, euros or pounds sterling. Holders of ordinary shares who have validly submitted US dollars, euros or pounds sterling currency elections by June 3, 2024 will be entitled to a dividend of US$0.344, €0.3166 or 26.94p per ordinary share, respectively. Absent any valid election to the contrary, persons holding their ordinary shares through Euroclear Nederland will receive their dividends in euros at the euro rate per ordinary share shown above. Absent any valid election...

Viridien launches new brand to accelerate growth as an advanced technology company

Written by Customer Service on June 10, 2024. Posted in Public Companies.

Paris, France – June 10, 2024 Viridien, formerly CGG, today launched its new brand at the 2024 EAGE Annual Conference in Oslo, marking the next stage in its strategic growth as an Advanced Technology, Digital and Earth Data company. Since this strategy was announced in 2018, the company has divested its data acquisition activities and increased the differentiation in its core businesses of Geoscience, Earth Data and Sensing & Monitoring. New Businesses are also positioned for growth in the Low-Carbon markets of Minerals & Mining and Carbon Storage, as well as in markets beyond energy in High-Performance Computing (HPC) and Infrastructure Monitoring. This portfolio uniquely positions Viridien to support clients in efficiently and responsibly solving their complex natural resource, digital, energy transition and infrastructure...

European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer

Written by Customer Service on June 10, 2024. Posted in Public Companies.

European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancer Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive resected non-small cell lung cancer, as demonstrated in the Phase III ALINA study1 Alecensa’s approval addresses an urgent unmet need in the early-stage setting where about half of all people experience disease recurrence following surgery, despite adjuvant chemotherapy2 Early diagnosis and treatment of lung cancer can reduce the burden associated with progressive disease and give people the best possible chance of cure3-6 Basel, 10 June 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Alecensa® (alectinib) monotherapy, as adjuvant...

IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica

Written by Customer Service on June 10, 2024. Posted in Mergers And Acquisitions.

IMCD_logo Logo IMCD ROTTERDAM, The Netherlands (10 June 2024) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Italy has signed an agreement to acquire 100% of the shares in Selechimica S.R.L. (“Selechimica”), an Italian distributor in the pharmaceutical industry. Headquartered in Milan, Italy, Selechimica distributes an extensive portfolio of Active Pharmaceutical Ingredients (APIs). With 3 employees, Selechimica represents leading suppliers and generated a revenue of approximately EUR 5 million in the financial year that ended December 31, 2023. “Selechimica is a valued distributor in the Italian API market. By acquiring Selechimica, IMCD will further strengthen its position in the Italian API market. We are eager to unlock the potential of this acquisition”,...

Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization

Written by Customer Service on June 10, 2024. Posted in Public Companies.

The test uses highly sensitive PCR technology, requiring only a single nasal-swab sample to provide rapid, accurate qualitative detection and differentiation among four of the most prevalent respiratory viruses for which differential diagnosis can drive appropriate treatment. Enables healthcare professionals to make confident clinical decisions and promptly determine appropriate treatment, with definitive results reported in just 20 minutes. Expands Roche’s extensive molecular point of care testing portfolio, offering greater flexibility to meet testing needs amid evolving regional prevalence of respiratory infections. Basel, 10 June 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its cobas® liat SARS-CoV-2, Influenza A/B &...

Hepsor’s Canadian subsidiary made its third investment in the Canadian real estate market

Written by Customer Service on June 10, 2024. Posted in Public Companies.

Hepsor SPV I Ltd, a Ontario-based subsidiary of Hepsor AS, made its third investment in the Canadian real estate market. An assembly of 7 properties was acquired in the much desired midtown Toronto neighborhood of Leaside, at 17-29 Glenavy Avenue, together with Canadian partners, Elysium Investments Inc. (Elysium). Elysium Glenavy Limited Partnership was formed to develop the property in which, in addition to Hepsor and Elysium, various Canadian and European investors are also participating. Fasken (www.fasken.com), one of Canada’s largest law firms, served as legal counsel for Hepsor, reviewing the partnership agreements and providing advice on deal structure and risk mitigation. The initial phase of the critical path of the project will involve the activation of a best-in-class consultant team led by the project architects, internationally...

Food Logistics Names Covenant Logistics Group as Recipient of 2024 Top 3PL & Cold Storage Providers Award

Written by Customer Service on June 10, 2024. Posted in Public Companies.

This award recognizes leading third-party logistics and cold storage providers in the cold food and beverage industry CHATTANOOGA, Tenn., June 10, 2024 (GLOBE NEWSWIRE) — Food Logistics named Covenant Logistics Group as one of the winners of this year’s Top 3PL & Cold Storage Providers Award, which recognizes leading 3PLs and cold storage providers in the cold food and beverage industry. “3PLs and cold storage providers remain a key puzzle piece to building and nurturing partnerships, cultivating resilience and helping companies in the cold food space overcome supply chain disruptions,” says Marina Mayer, Editor-in-Chief of Food Logistics and Supply & Demand Chain Executive. “Seventy-six percent of the winners plan to invest in software solutions this year. This is indicative of how forward-thinking these 3PLs and cold...

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Day: June 10, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice